Keryx Biopharmaceuticals Inc. (KERX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2018 | |||||
| ≡ | David Abrams - Abrams Capital Management | Sell 100.00% | 9,108,867 | 0.82 | |
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 25,791,678 | 0.69 | |
| Q3 2018 | |||||
| ≡ | David Abrams - Abrams Capital Management | Reduce 8.45% | 841,188 | 0.08 | |
| Q2 2018 | |||||
| ≡ | David Abrams - Abrams Capital Management | Add 2.38% | 230,879 | 0.02 | |
| Q4 2017 | |||||
| ≡ | David Abrams - Abrams Capital Management | Add 69.94% | 4,000,000 | 0.63 | |
| Q1 2016 | |||||
| ≡ | David Abrams - Abrams Capital Management | Add 3.99% | 219,176 | 0.05 | |
| Q4 2015 | |||||
| ≡ | David Abrams - Abrams Capital Management | Add 10.00% | 500,000 | 0.14 | |
| Q3 2015 | |||||
| ≡ | David Abrams - Abrams Capital Management | Buy | 5,000,000 | 1.26 | |
| Q2 2015 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 15.24% | 3,411,478 | 0.58 | |
| Q1 2015 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 22.30% | 4,080,200 | 0.90 | |
| Q3 2014 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 73.62% | 7,760,014 | 1.91 | |
| Q2 2014 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 67.01% | 4,229,136 | 1.08 | |
| Q1 2014 | |||||
| ≡ | Seth Klarman - Baupost Group | Buy | 6,310,850 | 2.65 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.